Diploma (LON:DPLM – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Royal Bank Of Canada in a research report issued on Tuesday, Digital Look reports. They currently have a GBX 7,400 price target on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 4.08% from the stock’s current price.
Several other equities analysts also recently weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their target price on Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research report on Wednesday, May 20th. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 7,000 price objective on shares of Diploma in a research report on Friday, May 29th. JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a research note on Monday, August 24th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a report on Monday, July 20th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Diploma currently has an average rating of “Moderate Buy” and a consensus price target of GBX 7,400.
Read Our Latest Stock Analysis on DPLM
Diploma Trading Down 0.8%
Insider Buying and Selling
In other Diploma news, insider Wilson Ng purchased 424 shares of the firm’s stock in a transaction that occurred on Thursday, July 16th. The shares were bought at an average price of GBX 7,066 per share, with a total value of £29,959.84. Also, insider Mandy Gradden acquired 1,000 shares of the stock in a transaction on Friday, July 17th. The shares were acquired at an average price of GBX 7,183 per share, with a total value of £71,830. Over the last 90 days, insiders have acquired 1,604 shares of company stock worth $11,447,718. Insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
- Five stocks we like better than Diploma
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
